GLP-1 drugs, originally developed for diabetes and obesity, may also curb addictive behaviors by acting on reward circuits in the brain. Early trials show reductions in alcohol intake, opioid seeking, ...
A new large-scale survey of students in Flanders and Brussels shows that fewer students are drinking alcohol and using ...
Popular weight loss drugs, like semaglutide (Ozempic, Wegovy) and liraglutide (Victoza), have transformed the way doctors treat diabetes and obesity. Now research suggests these meds — part of a class ...
Every day, drug and alcohol addiction shatters families, destabilizes neighborhoods, derails careers, and steals the lives of countless Americans. This National Alcohol and Drug Addiction Recovery ...
A new meta-analysis of over half a million people has found that spiritual practices like praying or meditating have a measurable impact. Spiritual practices, whether religious or not, lowered the ...
Aug. 13 (UPI) --A new federal study is linking the ability to quit smoking with longer-term success from the grip of drug or alcohol addiction, as well. Scientists at the National Institutes of Health ...
Researchers analyze 2.2 million genomes to show that addiction risk is primarily driven by broad genes affecting brain wiring ...
Lev Facher covers the U.S. addiction and overdose crisis. Smoking marijuana can lead to markedly lower short-term alcohol use, according to a first-of-its-kind study that adds a new layer to the ...
MIAMI — When Susan Akin first started injecting a coveted weight-loss drug early this year, the chaos in her brain quieted. The relentless cravings subsided — only they’d never been for food. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results